Keros Therapeutics Inc (KROS)
60.35
-2.72
(-4.31%)
USD |
NASDAQ |
Nov 14, 16:00
60.35
0.00 (0.00%)
After-Hours: 20:00
Keros Therapeutics Total Assets (Quarterly): 579.27M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 579.27M |
| June 30, 2024 | 455.02M |
| March 31, 2024 | 485.82M |
| December 31, 2023 | 370.02M |
| September 30, 2023 | 326.25M |
| June 30, 2023 | 356.31M |
| March 31, 2023 | 384.44M |
| December 31, 2022 | 306.78M |
| September 30, 2022 | 252.55M |
| June 30, 2022 | 226.66M |
| Date | Value |
|---|---|
| March 31, 2022 | 235.14M |
| December 31, 2021 | 255.25M |
| September 30, 2021 | 229.96M |
| June 30, 2021 | 243.46M |
| March 31, 2021 | 257.73M |
| December 31, 2020 | 269.44M |
| September 30, 2020 | 138.25M |
| June 30, 2020 | 150.44M |
| March 31, 2020 | 60.59M |
| December 31, 2019 | 10.96M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
10.96M
Minimum
Dec 2019
579.27M
Maximum
Sep 2024
279.72M
Average
256.49M
Median
Total Assets (Quarterly) Benchmarks
| Eli Lilly and Co | 75.61B |
| Regeneron Pharmaceuticals Inc | 37.44B |
| Scholar Rock Holding Corp | 226.86M |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 10.74M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 46.44M |
| Shareholders Equity (Quarterly) | 532.84M |
| Current Ratio | 19.03 |